Mood Disorder Treatment
Evidence-based therapy, medication management, and residential care for depression, bipolar disorder, and persistent mood disorders.
Key Takeaways
- Mood disorders include unipolar depression (MDD, PDD) and bipolar spectrum disorders (Bipolar I, Bipolar II, cyclothymia).
- First-line treatments include evidence-based psychotherapy (CBT, IPT, IPSRT) and medication (SSRIs, SNRIs, mood stabilizers, atypical antipsychotics).
- Roughly 30–40% of unipolar depression and 30%+ of bipolar disorder are treatment-resistant — evidence-based options exist for both.
- Co-occurring anxiety and substance use are very common — integrated treatment is essential.
- Residential care is appropriate when outpatient treatment isn’t working, when safety is a concern, or when daily function has collapsed.
Mood disorders — major depression, persistent depressive disorder, bipolar I, bipolar II, and cyclothymia — affect more than 20 million U.S. adults each year. They are the most common reason people seek mental health care, and they are highly treatable.
This page is a high-level overview of the mood disorder family. For depth on a specific diagnosis, see the dedicated pages linked below.
The Mood Disorder Family
Major Depressive Disorder (MDD) — at least five of nine depressive symptoms lasting two weeks or longer. See our Depression page for diagnosis and treatment detail.
Persistent Depressive Disorder (PDD) — a chronic, lower-grade depression with symptoms present most days for at least two years.
Bipolar I Disorder — at least one manic episode. See our Bipolar page for detail.
Bipolar II Disorder — recurring hypomanic episodes plus major depression.
Cyclothymic Disorder — chronic mood instability with hypomanic and depressive symptoms not meeting full criteria.
Evidence-Based Treatments Across Mood Disorders
Psychotherapy: CBT, Interpersonal Therapy (IPT), and Behavioral Activation for depression; CBT, Family-Focused Therapy, and Interpersonal and Social Rhythm Therapy (IPSRT) for bipolar disorder.
Medication: SSRIs/SNRIs for unipolar depression; mood stabilizers (lithium, lamotrigine, valproate) and atypical antipsychotics for bipolar disorder. Quetiapine and lurasidone are FDA-approved for bipolar depression specifically.
Neuromodulation (for treatment-resistant cases): TMS, ECT, esketamine.
Lifestyle interventions: structured sleep, exercise, social rhythm regulation, light therapy (seasonal patterns) — meaningful adjuncts in all mood disorders.
When Residential Care Makes Sense
Residential care for a mood disorder is appropriate when outpatient treatment hasn’t worked, when there are safety concerns (suicidal ideation, severe risk-taking), when co-occurring substance use is destabilizing treatment, or when daily function has collapsed. Most residential mood disorder programs run 30–60 days and combine daily individual therapy, group therapy, psychiatric medication management, and adjunctive services.
Co-Occurring Conditions
Mood disorders very commonly co-occur with anxiety disorders (60% lifetime comorbidity with depression), substance use disorders (30–40%), trauma disorders, and personality disorders. Integrated treatment — addressing the mood disorder and co-occurring conditions through one coordinated team — produces substantially better outcomes. See our Dual Diagnosis page for how integrated care is structured.
Insurance Coverage
Under federal Mental Health Parity law, most plans must cover mood disorder treatment at the same level as physical health care. Outpatient therapy and medication management are nearly always covered. IOP, PHP, and residential require pre-authorization but are covered when medically necessary. We verify benefits at no cost.
Frequently Asked Questions
What’s the difference between unipolar depression and bipolar disorder?
Unipolar depression involves only depressive episodes. Bipolar disorder involves manic or hypomanic episodes — often alternating with depression. Bipolar II is often misdiagnosed as unipolar depression because the depressive episodes typically bring people to treatment first.
Can mood disorders be cured?
Most mood disorders are managed rather than cured. With appropriate treatment, most people achieve substantial, lasting recovery — though periodic maintenance treatment may be needed to prevent relapse, particularly for bipolar disorder and recurrent depression.
How long does residential mood disorder treatment last?
Most programs run 30–60 days, with 90-day options for treatment-resistant cases or co-occurring conditions. Length depends on response to medication, safety, and discharge planning to PHP, IOP, or outpatient care.
Will insurance cover residential mood disorder treatment?
Under federal Mental Health Parity law, most plans must cover mood disorder treatment at the same level as physical health care. Residential typically requires pre-authorization based on medical necessity. We verify benefits at no cost.
Free, confidential phone assessment — same day.
A licensed admissions counselor will verify your insurance benefits, talk through what’s going on, and help match you to the right level of care. No cost, no commitment.